GTP cydohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson’s disease
GTP cydohydrolase I is the rate-limiting enzyme for the biosynthesis of tetrahydrobiopterin, which is the cofactor for tyrosine hydroxylase, the rate-limiting enzyme for dopamine biosynthesis. We found that dominantly inherited, hereditary progressive dystonia (HPD), first described by Segawa and also called dopa responsive dystonia (DRD), is caused by the mutations of GTP cydohydrolase I gene, the partial decrease in the enzyme activity, and probably in striatal dopamine level, to less than 20% of the normal values. Juvenile parkinsonism and Parkinson’s disease are also striatal dopamine deficiency, but no mutation in the enzyme has not been found, and they are supposed to be different from HPD/DRD in which no cell death of the nigrostriatal dopamine neurons occurs.
KeywordsTyrosine Hydroxylase Striatal Dopamine Level Juvenile Parkinsonism Dopa Responsive Dystonia Dopamine Biosynthesis
Unable to display preview. Download preview PDF.
- Furukawa Y, Nishi K, Kondo T, Mizuno Y, Narabayashi H (1993) CSF biopterine levels and clinical features of patients with juvenile parkinsonism. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds) Advances in neurology, vol 60. Raven Press, New York, pp 562–567Google Scholar
- Matsuura S, Murata S, Sugimoto T, Sawada M, Nagatsu T (1986) Preparation and cofactor activity of (6S)-tetrahydrobiopterin. Chem Express 1: 403–406Google Scholar
- Nagatsu T (1985) Biopterin cofactor and monoamine-synthesizing monooxygenases. In: Osborne NN (ed) Selected topics in neurochemistry. Pergamon Press, Oxford, pp 325–340Google Scholar
- Nagatsu T, Kato T, Nagatsu I, Kondo Y, Inagaki S, Iizuka R, Narabayashi H (1979) Catecholamine-related enzymes in the brain of patients with parkinsonism and Wilson’s disease. In: Poirier LJP, Sourkes TL, Bédard PJ (eds) Advances in neurology. Raven Press, New York, pp 283–242Google Scholar
- Nagatsu T, Horikoshi T, Sawada M, Nagatsu I, Kondo T, Iizuka R, Narabayashi H (1986) Biosynthesis of tetrahydrobiopterin in parkinsonian human brain. In: Yahr MD, Bergmann KJ (eds) Advances in neurology. Raven Press, New York, pp 223-226Google Scholar
- Nagatsu T, Nakahara D, Kobayashi K, Morita S, Sawada H, Mizuguchi T, Kiuchi K (1994) Peripherally administered (6R)-tetrahydrobiopterin increases in vivo tyrosine hydroxylase activity in the striatum measured by microdialysis both in normal mice and in transgenic mice carrying human tyrosine hydroxylase. Neurosci Lett 182: 44-46PubMedCrossRefGoogle Scholar
- Niederwieser A, Blau N, Wang M, Joller P, Atares M, Cardesa-Garcia J (1984) GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin dificiencies and muscular hypotonia. Eur J Pediatr 141: 208-214PubMedCrossRefGoogle Scholar
- Nygaard TG, Marsden CD, Duvoisin RC (1989) Dopa-responsive dystonia. Neurology 50: 377-384Google Scholar
- Segawa M, Ohmi K, Itoh S, Aoyama M, Hayakawa H (1971) Childhood basal ganglia disease with remarkable response to L-dopa, hereditary basal ganglia disease with marked diurnal fluctuation. Shinryo (Tokyo) 24: 667-672Google Scholar
- Segawa M, Nomura Y, Kase M (1986) Diurnally fluctuating hereditary progressive dystonia. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of clinical neurology. Elsevier, New York, pp 529-539Google Scholar
- Yokochi M (1993) Clinical pathological identification of juvenile parkinsonism in reference to dopa-responsivedisorders. In: Segawa H (ed) Hereditary progressive dystonia. Parthenon, Carnforth, pp 37-48Google Scholar